Heading to Anaheim next week for Engredea/Natural Products Expo West? Our clinical and regulatory team will be there with bells on, ready to answer all your burning questions!
Will you be attending Engredea/ Expo West next week?
Don't miss our highly anticipated lecture, entitled The IGEN Program: A New Solution for GMO Transparency, by Nutrasource President & CEO, William Rowe.
The lecture will take place Friday, March 6th from 12:00-1:00 pm at the Marriott, Grand Salon A/B.
A complimentary boxed lunch will be provided for attendees so be sure to arrive early! Seating is on a first come, first served basis.
William Rowe, president and CEO, co-founded Nutrasource Diagnostics Inc. (NDI) with Dr. Bruce J. Holub in May 2002 with the intent to market a novel omega-3 blood test. The launch of the test helped address the need for a straightforward, scientifically sound means of measuring an individual's omega-3 status, something that was lacking among the healthcare industry at the time. In an effort to meet the growing needs of the omega-3 supplement industry and beyond, NDI added divisions devoted to scientific and regulatory affairs, clinical trials and product analytics.
I am a product of Canadian universities, as are all three of my siblings. Education, especially post-secondary education, has been crucial in my personal and professional development. It has laid the groundwork which has allowed me to build a successful business that grows every year. A big part of what my company does is clinical research and clinical trials. So there you have it - all of my biases pertaining to this subject are out in the open.
As a follow-up to my previous post, I would like to provide a specific example of the gap between the published peer-reviewed scientific literature that will hold up to regulatory scrutiny.